x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

JACC This Week

American College of Cardiology

Weekly summary and focused insights of the high-impact cardiovascular research published in the JACC from Editor-in-Chief Harlan M. Krumholz, MD, SM, FACC, shaping cardiovascular care today.

health & fitness medicine

All Episodes

11:19

Comparative Effectiveness of Second-line...

JACC This Week ·

2024/08/26

In the September 3, 2024, JACC issue, a major study evaluates the cardiovascular outcomes of second-line antihyperglycemic agents in type 2 diabetes, comparing SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas. The research reveals that SGLT2 inhibitors and GLP-1 receptor agonists offer superior cardiovascular protection over the other agents, highlighting their importance for patients with cardiovascular conditions.

en

08:53

Anticoagulation Alone vs Anticoagulation Plus Aspirin...

JACC This Week ·

2024/08/26

In the September 3, 2024, issue of JACC, Dr. Samuel Reinhart and team find that using direct oral anticoagulants alone is associated with fewer adverse events compared to combining them with aspirin after left atrial appendage occlusion. Their large-scale study suggests this streamlined approach might be optimal, though further randomized trials are needed to address limitations and refine long-term antithrombotic strategies.

en

22:45

Antithrombotic Strategies for Patients with...

JACC This Week ·

2024/08/26

In the September 3rd, 2024 issue of JACC, a new scientific statement delves into antithrombotic strategies for peripheral artery disease (PAD), highlighting the challenges and advancements in treatment. The review emphasizes that while traditional therapies like aspirin and clopidogrel remain crucial, combining aspirin with low-dose rivaroxaban offers a promising approach for reducing major adverse events and limb outcomes, despite an increased bleeding risk.

en

24:11

JACC - September 3, 2024 Issue Summary

JACC This Week ·

2024/08/26

In this episode, Dr. Valentin Fuster reviews five pivotal studies from September 2024, focusing on antithrombotic strategies and diabetes treatments. Key insights include the efficacy of dual antithrombotic therapy over triple therapy, the benefits of anticoagulation alone post-left atrial appendage occlusion, and the superior cardiovascular outcomes of SGLT2 inhibitors and GLP-1 receptor agonists in diabetes management.

en

23:12

JACC - August 27, 2024 Issue Summary

JACC This Week ·

2024/08/19

In this episode, Dr. Valentin Fuster covers four original papers focusing on cardiovascular disease. Highlights include the effectiveness of semaglutide in reducing weight and improving heart failure symptoms, long-lasting effects of OPASAN on lipoprotein(a) levels, the impact of low-dose rivaroxaban plus aspirin on fragile patients post-revascularization, and the promising use of AI-based ECG for predicting biventricular dysfunction in congenital heart disease.

en

11:27

Deep Learning-Based Electrocardiogram Analysis...

JACC This Week ·

2024/08/19

Dr. Valentin Fuster evaluates a deep learning model designed to predict left and right ventricular dysfunction and dilation in congenital heart disease patients using ECG and CMR data. The research demonstrated that AI ECG can reliably identify significant cardiovascular issues, though future work should focus on refining thresholds and validating the model across diverse populations and healthcare settings.

en

11:12

The Off-Treatment Effects of Olpasiran on...

JACC This Week ·

2024/08/19

In this episode, Dr. Valentin Fuster explores findings from the Phase 2 OCEAN-LDO trial assessing the off-treatment effects of the RNA-based drug alpcisiran on lipoprotein(a) [Lp(a)] levels. The study found that high doses of alpcisiran reduced Lp(a) levels by up to 95% during treatment, with a sustained reduction of 27-76% persisting up to 96 weeks after discontinuation, and no new safety concerns emerged.

en

09:07

Treatment of Transcatheter Aortic Valve Thrombosis:...

JACC This Week ·

2024/08/19

Dr. Valentin Fuster discusses the treatment and diagnosis of transcatheter aortic valve thrombosis, focusing on its manifestations, diagnostic techniques using multi-slice computed tomography, and a proposed treatment algorithm. It highlights the difference between subclinical and clinical thrombosis and provides a detailed approach to managing both, including antiplatelet and anticoagulant therapies.

en

10:16

Efficacy of Semaglutide by Sex in Obesity-Related...

JACC This Week ·

2024/08/19

Dr. Valentin Fuster discusses a study on the efficacy of semaglutide for treating obesity-related heart failure with preserved ejection fraction, highlighting that the drug significantly reduced body weight and improved heart failure symptoms in both men and women. Notably, women experienced greater weight loss than men, but this did not translate into better improvement in heart failure-related symptoms, underscoring complex sex-related differences in cardiovascular health.

en

40:38

Structural Cardiac Interventions in Patients with...

JACC This Week ·

2024/08/19

In this episode, Dr. Valentin Fuster provides an overview of a scientific statement on structural cardiac interventions in heart failure. It details advances in percutaneous therapies for ventricular reshaping, valvular heart disease interventions, and tricuspid valve issues, while also highlighting gaps in current treatments and areas for future research.

en

09:13

Low-Dose Rivaroxaban Plus Aspirin in Fragile Patients...

JACC This Week ·

2024/08/19

Dr. Valentin Fuster discusses a study on the effects of low-dose rivaroxaban combined with aspirin in fragile patients after lower extremity revascularization, focusing on the balance between efficacy and safety. It highlights that while frailty increases the risk of adverse outcomes, rivaroxaban reduces ischemic events but also raises bleeding risks, regardless of frailty status. The editorial emphasizes that frailty should not preclude the use of combined antithrombotic therapy, advocating for

en

37:17

Optimizing Management of Stable Angina: A...

JACC This Week ·

2024/08/12

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

en

10:56

Clinical Significance of Diffusion-Weighted Brain MRI...

JACC This Week ·

2024/08/12

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

en

12:26

Clinical and Analytical Performance of a Novel...

JACC This Week ·

2024/08/12

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

en

09:42

Kidney and Cardiovascular Effectiveness of SGLT2...

JACC This Week ·

2024/08/12

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

en

09:04

Prescription Patterns for Sodium Glucose...

JACC This Week ·

2024/08/12

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

en

23:07

JACC - August 20, 2024 Issue Summary

JACC This Week ·

2024/08/12

Audio Summary of the August 20 issue of JACC, by Dr. Valentin Fuster, Emeritus Editor in Chief

en

08:41

Contemporary Pediatric Heart Transplant Waitlist...

JACC This Week ·

2024/08/05

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

en

10:16

Real-world 1-Year Results of Tricuspid Edge-to-Edge...

JACC This Week ·

2024/08/05

Audio Commentary by Dr. Valentin Fuster, Emeritus Editor in Chief

en

24:03

JACC - August 13, 2024 Issue Summary

JACC This Week ·

2024/08/05

Audio Summary of the August 13 issue of JACC, by Dr. Valentin Fuster, Emeritus Editor in Chief

en

1,263 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown